GL1X · GenesisL1 explorer

MolNFT v1 · #46912 · protein

Crystal structure of chicken C-src kinase domain in complex with the cancer drug imatinib.

2OIQ · Proto-oncogene tyrosine-protein kinase src: “Crystal structure of chicken C-src kinase domain in complex with the cancer drug imatinib.”. X-ray diffraction, 1 ligand (STI), 4 pockets (best druggability 0.74). MolNFT v1 #46912 on…

PDB
2OIQ
Type
protein
Length
530 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
STI
Pockets
4 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26540% helix, 16% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26541% helix, 17% strandP00523

Ligands and binding sites

  • STI · 4-(4-methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111770.740.7797STI, GOL
23370.630.7936empty
33170.580.7729empty
4530.330.7815empty

Interfaces

1 interface between chains.

  • A–B · 391 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 2OIQ · Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.